Response to nicotine

pathway activity — cross-omics
GO:0035094Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to nicotine pathway is significantly associated with the protein abundance of multiple proteins, with the PDAC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are S100A9, SP110_S256, and G6PD, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to nicotine activity versus S100A9 in PDAC (Pearson r = 0.06).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PDACS100A9 →+0.890+0.029.001<.00134
PDACSP110_S256 →-0.580-0.030.001<.00134
PDACG6PD →+0.187+0.018.008.00634
PDACILF2 →-0.093-0.025.006<.00134
HNSCPYCR2 →+0.468+0.042.001.00234
BRCAMSI2 →+0.380+0.033.003.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0035094 vs S100A9 — PDAC

Per-sample scatter of Response to nicotine activity vs S100A9 in PDAC.

Explore this scatter interactively →

Exploration